Nov 14, 2017 13:01 pm UTC| Business
NEW YORK, Nov. 14, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Weight Watchers...
MJ Holdings Announces Definitive Agreement to Acquire Red Earth; Paris Balaouras to Assume CEO Role
Nov 14, 2017 13:01 pm UTC| Business
MJ Holdings to acquire Red Earth, a holder of a provisional cannabis cultivation license in Las Vegas, Nevada.All-stock transaction; Red Earth unit holders will receive approximately 52.7 million common shares of MJ...
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results
Nov 14, 2017 13:01 pm UTC| Business
Completed Successful EMA Meeting for DCCR in Prader-Willi SyndromeContinued Preparations to Begin Phase III ProgramPresented Positive Updated Safety and Efficacy Data from Pilot Clinical Trial of DCCR for Treatment of...
Nov 14, 2017 13:01 pm UTC| Business
- AWE Program launched post successful demonstration of Actinium’s “Biobetter” capabilities as evidenced by superior experimental results with actinium-225 labeled daratumumab when compared to unlabeled daratumumab, a...
United Interiors Names DAN Nickerson Sales & Marketing Vice-President
Nov 14, 2017 13:01 pm UTC| Business
LOS ANGELES, Nov. 14, 2017 -- United Interiors (uiinteriors.com) has appointed DAN Nickerson, Vice-President of Sales Marketing, it was announced today by UI President Michael Cohen. With over 15 years of sales and...
NXT Energy Solutions Advises of Filing of Q3-2017 Results and Investor Call
Nov 14, 2017 13:01 pm UTC| Business
CALGARY, Alberta, Nov. 14, 2017 -- NXT Energy Solutions Inc. (“NXT Energy” or the “Company”) (TSX:SFD) (OTCQB:NSFDF) advises that its interim financial and operating results for the three month quarter ended September...
Atossa Genetics Announces Third Quarter 2017 Financial Results And Provides Company Update
Nov 14, 2017 13:01 pm UTC| Business
SEATTLE, Nov. 14, 2017 -- Atossa Genetics Inc. (NASDAQ:ATOS) (“Atossa” or the “Company”), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast...
China's Inflation Struggles: December CPI Signals Deflationary Concerns Amid Weak Demand
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update
Galaxy Z Flip FE and Watch8 Classic Rumored in Database Leak as Samsung Plans August Unpacked Reveal